Metabolomic Phenotyping for the Future of Personalized Medicine

Jacopo Troisi is an award-winning expert in the metabolomics field, with more than 100 papers in international peer-reviewed journals and several international patents. He has also spoken at dozens of international conferences. After graduating Summa cum Laude in biotechnology, he joined Medical School in the “Scuola Medica Salernitana” at the University of Salerno (Italy). He also completed studies in data analysis. Currently, he is a visiting professor of Metabolomics in both Salerno and Sannio Universities (Italy), cofounder and CEO at Theoreo Srl, a spin-off company of the University of Salerno, and COO at the European Biomedical Research Institute of Salerno (EBRIS). His research interests are mainly focused on metabolomic profiling to provide insights in human disease onset and for the development of diagnostic tools.

Martina Lombardi currently serves as Chief Scientific Officer at Theoreo srl, a spin-off company of the University of Salerno that deals with metabolomics, specifically the use of metabolomic profiling for the development of screening tests for human diseases. She also works at the “AOU Ruggi D’aragona” University Hospital in Salerno, Italy, where she was awarded a fellowship in internal medicine to study specifically the mechanisms underlying the progression of non-alcoholic fatty liver disease (NAFLD) and its association with metabolic syndrome and cardiovascular risk. She has published various papers in international peer-reviewed journals and presented her research results at metabolomic and bioinformatics and computational biology international conferences. She is currently actively engaged in the development of screening tests based on metabolomic profiling for various diseases, focusing mainly on oncological diseases, and is part of the scientific committee of a national conference on applications of metabolomic profiling in endometrial cancer screening.